# BMPR1A

## Overview
BMPR1A, or bone morphogenetic protein receptor type 1A, is a gene that encodes a transmembrane serine/threonine kinase receptor involved in the bone morphogenetic protein (BMP) signaling pathway. This receptor plays a critical role in various cellular processes, including cell growth, differentiation, and apoptosis, by mediating the effects of BMP ligands. The BMPR1A protein is essential for the differentiation of mesenchymal cells into chondrocytes during endochondral ossification, a key process in bone formation. It also regulates the activation of intracellular Smad proteins, which are crucial for gene transcription related to bone, cartilage, and cardiac tissue development (Russell2019Homozygous; Goulley2007BMP4BMPR1A). Mutations in the BMPR1A gene are associated with several genetic disorders, including juvenile polyposis syndrome and hereditary mixed polyposis syndrome, underscoring its significance in maintaining normal cellular functions and its potential impact on human health (Zhou2001Germline; Howe2001Germline).

## Structure
The BMPR1A protein, also known as bone morphogenetic protein receptor type 1A, is a serine/threonine kinase receptor involved in the BMP signaling pathway. Its primary structure includes a signal peptide, an extracellular ligand-binding domain, a transmembrane domain, and an intracellular kinase domain (Sanchez-Duffhues2020Bone). The extracellular domain (ECD) of BMPR1A is characterized by a three-finger toxin-like fold, which is rigid and structurally conserved, with five central β-strands forming the core (Klages2008The). This domain is stabilized by hydrophobic interactions, a network of hydrogen bonds, and five disulfide bonds (Klages2008The).

The secondary structure of BMPR1A includes alpha helices and beta sheets, with significant conformational changes occurring in the β4β5 loop upon BMP-2 binding, transitioning from a random coil to a short helix (Klages2008The). The tertiary structure involves the folding of these domains, with the C-terminal loop being highly defined due to its amphipathic nature (Klages2008The). The quaternary structure may involve dimerization, although specific details are not provided in the context.

Post-translational modifications of BMPR1A include phosphorylation, which is crucial for its activation and function in the BMP signaling pathway (Sanchez-Duffhues2020Bone). The flexibility of the β4β5 loop allows for promiscuous ligand-receptor interactions, enabling BMPR1A to adapt to various binding partners (Yadin2016Structural).

## Function
BMPR1A (bone morphogenetic protein receptor type 1A) is a serine/threonine kinase receptor that plays a pivotal role in the bone morphogenetic protein (BMP) signaling pathway. This receptor is crucial for various cellular processes, including cell growth, differentiation, and apoptosis. In healthy human cells, BMPR1A functions as a membrane receptor that facilitates the differentiation of mesenchymal cells into chondrocytes during endochondral ossification, a process essential for bone formation from a cartilage template (Russell2019Homozygous).

BMPR1A is involved in the activation of intracellular Smad proteins, specifically Smads 1, 5, and 8, which then translocate to the nucleus to regulate gene transcription. This signaling pathway is vital for maintaining proper bone, cartilage, and cardiac tissue formation (Russell2019Homozygous). In pancreatic β cells, BMPR1A signaling is essential for glucose-stimulated insulin secretion (GSIS), influencing the expression of genes critical for β cell function, including those involved in glucose sensing and insulin biosynthesis (Goulley2007BMP4BMPR1A).

BMPR1A is also active in skeletal tissues, where it is necessary for the proliferation, survival, and differentiation of chondrocytes, the cells responsible for cartilage formation (Yoon2005Bmpr1a). The receptor's activity is crucial for maintaining Sox protein expression, which is important for chondrogenic differentiation and cartilage development (Yoon2005Bmpr1a).

## Clinical Significance
Mutations in the BMPR1A gene are clinically significant as they are associated with several syndromes and conditions. Juvenile polyposis syndrome (JPS) is one of the primary conditions linked to BMPR1A mutations. JPS is characterized by the development of hamartomatous polyps in the gastrointestinal tract and an increased risk of gastrointestinal cancers. Germline mutations in BMPR1A, such as nonsense, frameshift, and splice-site mutations, lead to truncated receptors and are found in a significant proportion of JPS cases (Zhou2001Germline; Howe2001Germline). 

BMPR1A mutations are also implicated in hereditary mixed polyposis syndrome (HMPS), which involves mixed morphology polyps and a high risk of colorectal cancer. Large genomic deletions in BMPR1A have been identified in HMPS families, indicating a strong genetic link (Yean2009Germline). 

Additionally, BMPR1A is associated with congenital heart defects in the context of the 10q22q23 deletion syndrome, which includes features like facial dysmorphism and growth anomalies (Breckpot2012BMPR1A). 

The gene's role in these conditions highlights its importance in maintaining normal cellular processes, and disruptions can lead to significant pathologies.

## Interactions
BMPR1A, also known as bone morphogenetic protein receptor type 1A, is a transmembrane receptor that plays a crucial role in the BMP signaling pathway. It forms a complex with type II BMP receptors, such as BMPR2, to bind BMP ligands like BMP2, BMP4, and BMP7. Upon ligand binding, BMPR1A phosphorylates receptor-regulated SMADs (R-SMADs), specifically SMAD1, SMAD5, and SMAD8. These phosphorylated R-SMADs then form a complex with SMAD4, which translocates into the nucleus to regulate gene transcription (Howe2013BMPR1A; Sanchez-Duffhues2020Bone).

In zebrafish, BMPR1A interacts with the protein Bs69, which acts as a negative regulator by binding to the kinase domain of BMPR1A, interfering with its phosphorylation and activation of Smad1/5. This interaction is mediated by the Mynd domain of Bs69. The protein Mga can disrupt the Bs69-BMPR1A interaction, allowing for proper BMP signaling by enhancing the phosphorylation of Smad1/5/8 (Sun2018Mga).

BMPR1A is also subject to post-translational modifications, such as palmitoylation, which affects its function in neural stem cells and its association with membrane microdomains, influencing both canonical and noncanonical BMP signaling pathways (Wegleiter2019Palmitoylation).


## References


[1. (Breckpot2012BMPR1A) Jeroen Breckpot, Léon-Charles Tranchevent, Bernard Thienpont, Marijke Bauters, Els Troost, Marc Gewillig, Joris R. Vermeesch, Yves Moreau, Koenraad Devriendt, and Hilde Van Esch. Bmpr1a is a candidate gene for congenital heart defects associated with the recurrent 10q22q23 deletion syndrome. European Journal of Medical Genetics, 55(1):12–16, January 2012. URL: http://dx.doi.org/10.1016/j.ejmg.2011.10.003, doi:10.1016/j.ejmg.2011.10.003. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2011.10.003)

[2. (Yoon2005Bmpr1a) Byeong S. Yoon, Dmitry A. Ovchinnikov, Isaac Yoshii, Yuji Mishina, Richard R. Behringer, and Karen M. Lyons. Bmpr1a and bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proceedings of the National Academy of Sciences, 102(14):5062–5067, March 2005. URL: http://dx.doi.org/10.1073/pnas.0500031102, doi:10.1073/pnas.0500031102. This article has 366 citations.](https://doi.org/10.1073/pnas.0500031102)

[3. (Sanchez-Duffhues2020Bone) Gonzalo Sanchez-Duffhues, Eleanor Williams, Marie-Jose Goumans, Carl-Henrik Heldin, and Peter ten Dijke. Bone morphogenetic protein receptors: structure, function and targeting by selective small molecule kinase inhibitors. Bone, 138:115472, September 2020. URL: http://dx.doi.org/10.1016/j.bone.2020.115472, doi:10.1016/j.bone.2020.115472. This article has 83 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2020.115472)

[4. (Goulley2007BMP4BMPR1A) Joan Goulley, Ulf Dahl, Nathalie Baeza, Yuji Mishina, and Helena Edlund. Bmp4-bmpr1a signaling in β cells is required for and augments glucose-stimulated insulin secretion. Cell Metabolism, 5(3):207–219, March 2007. URL: http://dx.doi.org/10.1016/J.CMET.2007.01.009, doi:10.1016/j.cmet.2007.01.009. This article has 149 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/J.CMET.2007.01.009)

[5. (Howe2001Germline) James R. Howe, Jennifer L. Bair, Mohamed G. Sayed, Mary E. Anderson, Frank A. Mitros, Gloria M. Petersen, Victor E. Velculescu, Giovanni Traverso, and Bert Vogelstein. Germline mutations of the gene encoding bone morphogenetic protein receptor 1a in juvenile polyposis. Nature Genetics, 28(2):184–187, June 2001. URL: http://dx.doi.org/10.1038/88919, doi:10.1038/88919. This article has 485 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/88919)

[6. (Yean2009Germline) Peh Yean Cheah, Yu Hui Wong, Yuk Ping Chau, Carol Loi, Kiat Hon Lim, Jit Fong Lim, Poh Koon Koh, and Kong Weng Eu. Germline bone morphogenesis protein receptor 1a mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. American Journal of Gastroenterology, 104(12):3027–3033, December 2009. URL: http://dx.doi.org/10.1038/ajg.2009.542, doi:10.1038/ajg.2009.542. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ajg.2009.542)

[7. (Sun2018Mga) Xiaoyun Sun, Ji Chen, Yanyong Zhang, Mumingjiang Munisha, Scott Dougan, and Yuhua Sun. Mga modulates bmpr1a activity by antagonizing bs69 in zebrafish. Frontiers in Cell and Developmental Biology, September 2018. URL: http://dx.doi.org/10.3389/fcell.2018.00126, doi:10.3389/fcell.2018.00126. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2018.00126)

[8. (Russell2019Homozygous) Bianca E. Russell, Diana Rigueur, Kathryn N. Weaver, Kristen Sund, Janet S. Basil, Robert B. Hufnagel, Cynthia A. Prows, Alan Oestreich, Lihadh Al‐Gazali, Robert J Hopkin, Howard M. Saal, Karen Lyons, and Andrew Dauber. Homozygous missense variant in bmpr1a resulting in bmpr signaling disruption and syndromic features. Molecular Genetics &amp; Genomic Medicine, September 2019. URL: http://dx.doi.org/10.1002/mgg3.969, doi:10.1002/mgg3.969. This article has 7 citations.](https://doi.org/10.1002/mgg3.969)

[9. (Howe2013BMPR1A) James R. Howe, Fadi S. Dahdaleh, Jennifer C. Carr, Donghong Wang, Scott K. Sherman, and James R. Howe. Bmpr1a mutations in juvenile polyposis affect cellular localization. Journal of Surgical Research, 184(2):739–745, October 2013. URL: http://dx.doi.org/10.1016/j.jss.2013.01.015, doi:10.1016/j.jss.2013.01.015. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jss.2013.01.015)

[10. (Klages2008The) Jochen Klages, Alexander Kotzsch, Murray Coles, Walter Sebald, Joachim Nickel, Thomas Müller, and Horst Kessler. The solution structure of bmpr-ia reveals a local disorder-to-order transition upon bmp-2 binding. Biochemistry, 47(46):11930–11939, October 2008. URL: http://dx.doi.org/10.1021/bi801059j, doi:10.1021/bi801059j. This article has 45 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi801059j)

[11. (Zhou2001Germline) Xiao-Ping Zhou, Kelly Woodford-Richens, Rainer Lehtonen, Keisuke Kurose, Micheala Aldred, Heather Hampel, Virpi Launonen, Sanno Virta, Robert Pilarski, Reijo Salovaara, Walter F. Bodmer, Beth A. Conrad, Malcolm Dunlop, Shirley V. Hodgson, Takeo Iwama, Heikki Järvinen, Ilmo Kellokumpu, J.C. Kim, Barbara Leggett, David Markie, Jukka-Pekka Mecklin, Kay Neale, Robin Phillips, Juan Piris, Paul Rozen, Richard S. Houlston, Lauri A. Aaltonen, Ian P.M. Tomlinson, and Charis Eng. Germline mutations in bmpr1a/alk3 cause a subset of cases of juvenile polyposis syndrome and of cowden and bannayan-riley-ruvalcaba syndromes*. The American Journal of Human Genetics, 69(4):704–711, October 2001. URL: http://dx.doi.org/10.1086/323703, doi:10.1086/323703. This article has 188 citations.](https://doi.org/10.1086/323703)

[12. (Wegleiter2019Palmitoylation) Thomas Wegleiter, Kilian Buthey, Daniel Gonzalez-Bohorquez, Martina Hruzova, Muhammad Khadeesh bin Imtiaz, Andrin Abegg, Iliana Mebert, Adriano Molteni, Dominik Kollegger, Pawel Pelczar, and Sebastian Jessberger. Palmitoylation of bmpr1a regulates neural stem cell fate. Proceedings of the National Academy of Sciences, 116(51):25688–25696, November 2019. URL: http://dx.doi.org/10.1073/pnas.1912671116, doi:10.1073/pnas.1912671116. This article has 21 citations.](https://doi.org/10.1073/pnas.1912671116)

[13. (Yadin2016Structural) David Yadin, Petra Knaus, and Thomas D. Mueller. Structural insights into bmp receptors: specificity, activation and inhibition. Cytokine &amp; Growth Factor Reviews, 27:13–34, February 2016. URL: http://dx.doi.org/10.1016/j.cytogfr.2015.11.005, doi:10.1016/j.cytogfr.2015.11.005. This article has 175 citations.](https://doi.org/10.1016/j.cytogfr.2015.11.005)